Kalaris Therapeutics
KLRS4.1903.01% ( -0.130 )
Q1 FY2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Preview: Kalaris Therapeutics(KLRS) predict that the Revenue is 0 (--%), Meet estimate;the EBIT is -11.83 M (-14.28%), Miss estimate;the EPS is -0.46 (--%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.00B--
0.00B--
0.00B--%
EBITMiss expectations
-0.01B14.28%
-0.01B13.98%
-0.00B0.30%
EPSExceed expectations
-0.46--
-0.525--
+0.0650--%
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf